Long telomere length predicts poor clinical outcome in esophageal cancer patients

被引:8
作者
Lv, Yanyan [1 ,2 ]
Zhang, Yong [3 ]
Li, Xinru [1 ]
Ren, Xiaojuan [1 ]
Wang, Meichen [1 ]
Tian, Sijia [1 ]
Hou, Peng [1 ,4 ]
Shi, Bingyin [1 ,4 ]
Yang, Qi [1 ,4 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Endocrinol, Xian 710061, Peoples R China
[2] Xian 5 Hosp, Dept Rheumatol, Xian 710082, Peoples R China
[3] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Thorac Surg, Xian 710061, Peoples R China
[4] Xi An Jiao Tong Univ, Affiliated Hosp 1, Key Lab Tumor Precis Med Shaanxi Prov, Xian 710061, Peoples R China
基金
中国国家自然科学基金;
关键词
Esophageal cancer; Relative telomere length; Biomarker; Clinical outcome; REVERSE-TRANSCRIPTASE EXPRESSION; SQUAMOUS-CELL CARCINOMA; CHROMOSOMAL INSTABILITY; GASTRIC-CANCER; INCREASED RISK; LUNG-CANCER; LESIONS; CARCINOGENESIS; PROGRESSION; MECHANISMS;
D O I
10.1016/j.prp.2016.11.010
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Abnormal telomere length is widely reported in various human cancers, and it is considered to be an important hallmark of cancer. However, there is remarkably little consensus on the value of telomere length in the prognostic evaluation of esophageal cancers. Here, we attempted to determine the association of variable telomere length with clinical outcome of esophageal cancer patients. Materials and methods: Using real-time quantitative PCR, we examined relative telomere lengths (RTL) in a cohort of esophageal cancer and normal esophageal tissues, and statistically investigated the association between RTL and clinical outcomes of esophageal cancer patients. Results: The majority of esophageal cancers in this study had longer RTLs as compared to adjacent non tumor tissues. Enhanced tumor RTL was associated with smoking habit, poor differentiation, advanced tumor stage, lymph node metastasis and cancer related death. In particular, a close relationship between longer RTL and poor survival was fully demonstrated by using cox regression and Kaplan-Maier survival curves. Conclusions: We found frequent telomere elongation in esophageal cancer tissues, and demonstrated longer RTL may be an independent poor prognostic factor for esophageal cancer patients. (C) 2016 Elsevier GmbH. All rights reserved.
引用
收藏
页码:113 / 118
页数:6
相关论文
共 50 条
  • [1] Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients
    Tastekin, Didem
    Kargin, Suleyman
    Karabulut, Mehmet
    Yaldiz, Naile
    Tambas, Makbule
    Gurdal, Necla
    Tatli, Ali Murat
    Arslan, Deniz
    Gok, Ali Fuat Kaan
    Aykan, Faruk
    TUMOR BIOLOGY, 2014, 35 (12) : 11871 - 11877
  • [2] p38 predicts depression and poor outcome in esophageal cancer
    Cheng, Yao
    Qiao, Zhe
    Dang, Chengxue
    Zhou, Bin
    Li, Shaomin
    Zhang, Wei
    Jiang, Jiantao
    Song, Yongchun
    Zhang, Jin
    Diao, Dongmei
    ONCOLOGY LETTERS, 2017, 14 (06) : 7241 - 7249
  • [3] Telomere length predicts for outcome to FCR chemotherapy in CLL
    Norris, Kevin
    Hillmen, Peter
    Rawstron, Andrew
    Hills, Robert
    Baird, Duncan M.
    Fegan, Christopher D.
    Pepper, Chris
    LEUKEMIA, 2019, 33 (08) : 1953 - 1963
  • [4] Short telomere length in peripheral blood leukocyte predicts poor prognosis and indicates an immunosuppressive phenotype in gastric cancer patients
    Qu, Falin
    Li, Renli
    He, Xianli
    Li, Qiucheng
    Xie, Shuang
    Gong, Li
    Ji, Gang
    Lu, Jianguo
    Bao, Guoqiang
    MOLECULAR ONCOLOGY, 2015, 9 (03) : 727 - 739
  • [5] Clinical outcome of esophageal cancer patients with history of gastrectomy
    Wada, H
    Doki, Y
    Nishioka, K
    Ishikawa, O
    Kabuto, T
    Yano, M
    Monden, M
    Imaoka, S
    JOURNAL OF SURGICAL ONCOLOGY, 2005, 89 (02) : 67 - 74
  • [6] Clinical utility of telomere length measurements in cancer
    Pepper, Chris
    Norris, Kevin
    Fegan, Christopher
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2020, 60 : 107 - 111
  • [7] Increased MALAT1 expression predicts poor prognosis in esophageal cancer patients
    Huang, Congxiu
    Yu, Zhilong
    Yang, Hao
    Lin, Yu
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 83 : 8 - 13
  • [8] p53 overexpression is a prognosticator of poor outcome in esophageal cancer
    Melling, Nathaniel
    Norrenbrock, Sonja
    Kluth, Martina
    Simon, Ronald
    Hube-Magg, Claudia
    Steurer, Stefan
    Hinsch, Andrea
    Burandt, Eike
    Jacobsen, Frank
    Wilczak, Waldemar
    Quaas, Alexander
    Bockhorn, Maximillian
    Grupp, Katharina
    Tachezy, Michael
    Izbicki, Jakob
    Sauter, Guido
    Gebauer, Florian
    ONCOLOGY LETTERS, 2019, 17 (04) : 3826 - 3834
  • [9] Mesenchymal phenotype after chemotherapy is associated with chemoresistance and poor clinical outcome in esophageal cancer
    Hara, Johji
    Miyata, Hiroshi
    Yamasaki, Makoto
    Sugimura, Keijiro
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Nakajima, Kiyokazu
    Takiguchi, Shuji
    Mori, Masaki
    Doki, Yuichiro
    ONCOLOGY REPORTS, 2014, 31 (02) : 589 - 596
  • [10] Neuronal protein synuclein γ predicts poor clinical outcome in breast cancer
    Guo, Jianping
    Shou, Chengchao
    Meng, Lin
    Jiang, Beihai
    Bin Dong
    Yao, Lihua
    Xie, Yuntao
    Zhang, Jianzhi
    Chen, Yiding
    Budman, Daniel R.
    Shi, Yuenian Eric
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (06) : 1296 - 1305